Sai Parenteral's Limited (NSE:SAIPARENT)

India · Delayed Price · Currency is INR

540.85

-2.55 (-0.47%)

At close: Aug 21, 2026

37.97% (1Y)

Market Cap	23.89B
Revenue (ttm)	5.26B +443.7%
Net Income	207.67M +374.6%
EPS	17.89 +482.5%
Shares Out	44.18M
PE Ratio	30.24
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58,240
Open	546.15
Previous Close	543.40
Day's Range	539.00 - 546.20
52-Week Range	392.00 - 706.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Sai Parenteral's

Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, and dermatology in various dosage forms, including injectables, tablets, capsules, liquid orals, and ointments. The company ... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1988

Employees 269

Stock Exchange National Stock Exchange of India

Ticker Symbol SAIPARENT

Full Company Profile

Financial Performance

In fiscal year 2026, Sai Parenteral's's revenue was 3.81 billion, an increase of 133.59% compared to the previous year's 1.63 billion. Earnings were 142.59 million, a decrease of -1.35%.

Financial Statements